Clinical observational study of bacteriophage therapy in skin and soft tissue infections in georgia

This Special Notice announces the Department of the Army Medical Command's intent to sole source a clinical observational study of bacteriophage therapy in skin and soft tissue infections to the Eliava Phage Therapy Center. The Center will negotiate solely to provide study personnel meeting regulatory requirements, provide frequent updates on patient enrollment and lab results, and ensure all investigators receive protocol training and familiarity with study documents.

The purpose is to have the Center conduct testing according to the protocol and institutional SOPs, log and track samples transferred between the contractor and US Army Medical Research Directorate - Georgia, and capture a complete data set for each participant. Interested parties may submit capability information by February 23, 2022 to identify interest in the opportunity, though sole sourcing is at the Army's discretion if no responses are received. Investigators will adhere to the study protocol and institutional SOPs in collecting a full data set for each participant. This Special Notice announces an opportunity for a clinical observational study on bacteriophage therapy and provides instructions for potential contractors to respond by the given deadline if interested in the work.